Courtney Babb, Henry Badji, Md Taufiqur Rahman Bhuiyan, Jennifer Cornick, Sonia Qureshi, Catherine Sonye, Wagner V Shapiama Lopez, Mehreen Adnan, Hannah E Atlas, Kehkashan Begum, Stephanie A Brennhofer, Bubacarr E Ceesay, Abdoulie K Ceesay, Nigel A Cunliffe, Paul F Garcia Bardales, Shahinur Haque, Bri'Anna Horne, M Jahangir Hossain, Junaid Iqbal, Md Taufiqul Islam, Sadia Islam, Farhana Khanam, Karen L Kotloff, Thandizo Malemia, Katia Manzanares Villanueva, Gertrude Malola Million, Vitumbiko Munthali, John Benjamin Ochieng, Billy Ogwel, Maribel Paredes Olortegui, Richard Omore, Patricia B Pavlinac, James A Platts-Mills, Khandra T Sears, Ousman Secka, Sharon M Tennant, Pablo Peñataro Yori, Mohammad Tahir Yousafzai, Khuzwayo C Jere, Margaret N Kosek, Stephen Munga, Usman N Ikumapayi, Firdausi Qadri, Farah Naz Qamar, Elizabeth T Rogawski McQuade
BACKGROUND: The measurement of fecal inflammatory biomarkers among individuals presenting to care with diarrhea could improve the identification of bacterial diarrheal episodes that would benefit from antibiotic therapy. We reviewed prior literature in this area and describe our proposed methods to evaluate 4 biomarkers in the Enterics for Global Health (EFGH) Shigella surveillance study. METHODS: We systematically reviewed studies since 1970 from PubMed and Embase that assessed the diagnostic characteristics of inflammatory biomarkers to identify bacterial diarrhea episodes...
March 2024: Open Forum Infectious Diseases